Ignis Therapeutics is based in Shanghai, China. It has raised $185M in total funding. Latest round: Series A.
Ignis Therapeutics is based in Shanghai, China. Ignis Therapeutics has raised $185M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in November 2021. The round record for Ignis Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include 6 Dimensions Capital, SK Biopharmaceuticals, Ruentex Group, KB Investment, Mubadala Investment Company, HBM Healthcare Investments and 1 others. 7 distinct backers are named across the disclosed rounds.
Ignis Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026